MicroRNAs in cancer biology and therapy: Current status and perspectives
Authors:
Open Access
- 1 September 2014
- journal article
- Published by Elsevier in Genes & Diseases
- Vol. 1 (1) , 53-63
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA127277, R01CA182528, F31 CA171702)
- Howard Hughes Med-into-Grad Translational Research Program
- American Cancer Society
- Spastic Paralysis Foundation
This publication has 169 references indexed in Scilit:
- Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomasInternational Journal of Cancer, 2012
- Plasma Components Affect Accuracy of Circulating Cancer-Related MicroRNA QuantitationThe Journal of Molecular Diagnostics, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to CancerMolecular Cell, 2010
- Posttranscriptional Regulation of MicroRNA Biogenesis in AnimalsMolecular Cell, 2010
- Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid LeukemiaCancer Cell, 2010
- miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic BlastsCell, 2010
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008